#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic thrombocytopenic purpura Renal cancer metastatic Thyroid cancer metastatic Leukocyte adhesion deficiency Von Willebrand's disease Erythema multiforme Li-Fraumeni syndrome Cognitive disorder Allogenic stem cell transplantation Fibrosarcoma Nephropathy Cutaneous T-cell lymphoma stage I Acute leukaemia Glomerulonephritis chronic Toxic epidermal necrolysis More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Basic Information Synovial sarcoma metastatic IgA nephropathy – Diagnostics Lymphangiosarcoma – Life with Disease Breast angiosarcoma metastatic – Basic Information Haemophagocytic lymphohistiocytosis – Treatment Hereditary motor and sensory neuropathy – Treatment Gastrointestinal stromal tumour – Treatment Factor VIII deficiency – Treatment Langerhans cell sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cilgavimab TALADEGIB Ly3454738 Benzathine Benzylpenicillin Troriluzole Meropenem Clopidogrel Hydrogen Sulfate Ipratropium Bromide Cpk850 Terlipressin Everolimus Migalastat Corifollitropin Alfa Iloprost Trometamol Valine Vorinostat Sotagliflozin Magnesium Hydroxide Indometacin Ph. Eur. Clascoterone More therapies…

    Learn about Your Condition

    Thymoma Neurotrophic keratopathy Leber's congenital amaurosis Usher's syndrome Retroperitoneal cancer Hypertension Alcoholism Rhabdomyosarcoma recurrent Back pain Angiosarcoma metastatic Injury Mucopolysaccharidosis Malabsorption Large cell lung cancer Cervix carcinoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Treating Early Borderline Lesions in Low-Risk Kidney Transplant Patients with Rabbit Anti-T Lymphocyte Immunoglobulin

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    Spain

  • Study on Adjusting Omalizumab Dosage for Patients with Severe Allergic Asthma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Omalizumab
    Spain

  • Study on Adjusting Adalimumab Treatment for Patients with Chronic Non-Infectious Uveitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infective uveitis
    Investigated Drugs:
    • Adalimumab
    France

  • Study on Durvalumab and Chemotherapy for Patients with Relapsed Stage III Non-Small Cell Lung Cancer After Chemoradiotherapy and Durvalumab Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Durvalumab
    Italy

  • Study on the Safety and Effectiveness of DT-DEC01 for Patients with Duchenne Muscular Dystrophy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Poland

  • Study of oral lidocaine (ORE-001) to reduce abdominal discomfort and early satiety in patients with anorexia nervosa

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Anorexia nervosa
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    Italy
Previous Page
1 … 826 827 828 829 830 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!